Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_609568
Proper Citation: (Bio-Rad Cat# OBT0030, RRID:AB_609568)
Target Antigen: RAT ANTI BrdU
Host Organism: rat
Clonality: monoclonal
Comments: manufacturer recommendations: IgG2a; IgG2a Flow Cytometry, Immunohistology - Paraffin, Immunofluorescence; Immunohistochemistry - fixed; Immunofluorescence; Flow Cytometry; Immunohistochemistry
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for RAT ANTI BrdU.
Possibly Non-Specific
Extracted Antibody Information: "In order to expose the proliferation markers, tissue sections were pretreated to break double-stranded DNA into single strands, by incubation in 2 N HCl in PB containing 0.3% Triton X-100 (PB-T) for 50 min. After rinsing in PB (3 × 10 min), sections were incubated overnight at 40°C in both rat anti BrdU-CldU (AbD Serotec Cat# OBT0030, RRID:AB_609568;"
Extracted Specificity Statement: "On the other hand, the rat anti-BrdU antibody, but not the mouse anti-BrdU monoclonal antibody, detects CldU in tissue samples from animals exposed to this thymidine analog (Vega and Peterson, 2005). Cross reactivity of primary antibodies with the thymidine analogs was tested by incubation of sections of CldU only and IdU only treated animals with anti-IdU or anti-CldU antibodies, respectively (followed by incubation in the corresponding secondary antibodies; Supplementary Figure 1)."
Data was mined by Antibody Watch (https://arxiv.org/pdf/2008.01937.pdf), from PMID:25249943
Possibly Non-Specific
Extracted Antibody Information: "After rinsing in PB (3 × 10 min), sections were incubated overnight at 40°C in both rat anti BrdU-CldU (AbD Serotec Cat# OBT0030, RRID:AB_609568;"
Extracted Specificity Statement: "On the other hand, the rat anti-BrdU antibody, but not the mouse anti-BrdU monoclonal antibody, detects CldU in tissue samples from animals exposed to this thymidine analog (Vega and Peterson, 2005). Cross reactivity of primary antibodies with the thymidine analogs was tested by incubation of sections of CldU only and IdU only treated animals with anti-IdU or anti-CldU antibodies, respectively (followed by incubation in the corresponding secondary antibodies; Supplementary Figure 1)."
Data was mined by Antibody Watch (https://arxiv.org/pdf/2008.01937.pdf), from PMID:25249943
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.